Krystal Biotech
KRYS
KRYS
98 hedge funds and large institutions have $623M invested in Krystal Biotech in 2020 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 47 increasing their positions, 30 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
11% less funds holding
Funds holding: 110 → 98 (-12)
75% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 16
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1.06M
Holders
98
Holding in Top 10
1
Calls
–
Puts
$1.06M
Top Buyers
| 1 | +$11.7M | |
| 2 | +$10.6M | |
| 3 | +$7.87M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$5.37M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
+$3.97M |
Top Sellers
| 1 | -$23.2M | |
| 2 | -$7.55M | |
| 3 | -$4.41M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$1.83M |
| 5 |
Renaissance Technologies
New York
|
-$1.8M |